ROSEN, A LEADING LAW FIRM, Encourages Klarna Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KLAR — Neutral
KLAR GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of securities of Klarna Group plc (NYSE: KLAR) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna's September 2025 initial public offering (the “IPO”). If you wish to serve as lead plaintiff, you must move the Court no later than February 20, 2026.
Inspire Medical (INSP) Crashes Over 32%, “Inspire V” Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 — Neutral
INSP GlobeNewsWire — December 25, 2025SAN FRANCISCO, Dec. 25, 2025 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact its attorneys before the January 5, 2026, Lead Plaintiff Deadline.
Bronstein, Gewirtz & Grossman LLC Urges Freeport-McMoRan Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
FCX GlobeNewsWire — December 25, 2025New class action for Freeport-McMoRan Inc. (FCX) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/12/2026.
Bronstein, Gewirtz & Grossman LLC Urges Alexandria Real Estate Equities, Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
ARE GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Alexandria securities between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”).
Bronstein, Gewirtz & Grossman, LLC Urges Gauzy Ltd. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
GAUZ GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Gauzy Ltd. (“Gauzy” or “the Company”) (NASDAQ: GAUZ) and certain of its officers.
Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
TLX GlobeNewsWire — December 25, 2025New class action for Telix Pharmaceuticals Limited investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/5/2026
Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
PRGO GlobeNewsWire — December 25, 2025New class action for Perrigo Company plc (PRGO) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026.
Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
FFIV GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against F5, Inc. (NASDAQ: FFIV) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired F5 securities between October 28, 2024 and October 27, 2025, both dates inclusive (the “Class Period”).
Bronstein, Gewirtz & Grossman LLC Urges Jayud Global Logistics Ltd. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
JYD GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Jayud Global Logistics Ltd. (NASDAQ: JYD) and certain of its officers.
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
INSP GlobeNewsWire — December 25, 2025New class action for Inspire Medical Systems, Inc. investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/5/2026
Bronstein, Gewirtz & Grossman LLC Urges Coupang, Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
CPNG GlobeNewsWire — December 25, 2025New class action for Coupang, Inc. (CPNG) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/17/2026.
Bronstein, Gewirtz & Grossman LLC Urges Integer Holdings Corporation Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
ITGR GlobeNewsWire — December 25, 2025New class action for Integer Holdings (ITGR) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/9/2026.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sprouts Farmers Market, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SFM — Neutral
SFM GlobeNewsWire — December 25, 2025NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 and October 29, 2025, both dates inclusive (the “Class Period”), of the important January 26, 2026 lead plaintiff deadline.
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
QNTM GlobeNewsWire — December 25, 2025New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026
Bronstein, Gewirtz & Grossman LLC Urges Firefly Aerospace Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
FLY GlobeNewsWire — December 25, 2025New class action for Firefly Aerospace Inc. (FLY) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/12/2026
TLX CLASS ACTION DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain — Neutral
TLX GlobeNewsWire — December 25, 2025SAN FRANCISCO, Dec. 25, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 9, 2026.
Bronstein, Gewirtz & Grossman LLC Urges Skye Bioscience, Inc. Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
SKYE GlobeNewsWire — December 25, 2025New class action for Skye Bioscience, Inc. (SKYE) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 1/16/2026
Nike's Revival of Classic Brand Has a Hitch—Soccer Coach Grabbed the Trademark — Negative
NKE WSJ — December 25, 2025The nostalgic Total 90 product line is central to Nike's World Cup plans. It just never renewed the trademark rights.
Microsoft May Look Pricey, But Customers Can't Walk Away — Positive
MSFT MarketBeat — December 25, 2025Microsoft Corp. NASDAQ: MSFT stock is up more than 15% in 2025. Even after the latest slide in technology stocks, the stock is still up about 3% in the last month.
PG&E Corp. is repositioning for consistent EPS growth and strong shareholder returns, despite a legacy of wildfire-related challenges. PCG trades at a low ~10.5x P/E, targets 9%+ annual EPS growth, and plans a 20% dividend payout ratio by 2028. Massive $73 billion capital deployment through 2030 will expand the rate base, with no new equity issuance and a focus on grid modernization and renewables.